Form 13F security
GANX · GAIN THERAPEUTICS INC
Class COM
As filed on Form 13F — long US-listed positions only. No shorts, cash, bonds, or non-13F assets appear here.
Filed up to 45 days after quarter end; holdings may have changed since.
Tracked managers holding it
Share and principal positions
| Manager | Quarter | Value | % of portfolio | SH/PRN qty | Put/call |
|---|---|---|---|---|---|
| DME Capital Management, LP — David Einhorn — Greenlight | 2026-06-30 | $1.1M | <0.1% | SH 566,130 | — |
Total $1.1M across 1 of 69 managers.
Sums are across tracked reports, not unique economic ownership.
DME Capital Management, LP — Combined report.
Filed rows (2) — as filed
The filer reports some securities in multiple rows; rows are shown as filed.
| Manager | Class | Put/call | Value | % of portfolio | SH/PRN qty | Source |
|---|---|---|---|---|---|---|
| DME Capital Management, LP | COM | — | $1.0M | <0.1% | SH 492,130 | 0001172661-26-003786 |
| DME Capital Management, LP | COM | — | <$1M | <0.1% | SH 74,000 | 0001172661-26-003786 |